Cizzle Biotechnology Holdings (CIZ) Share Price

Health Care Sector


NOTE: This is based on 0 open tips for Cizzle Biotechnology Holdings (CIZ)


Cizzle Biotechnology Holdings (CIZ)
Latest Quote Price

1.75p

Cizzle Biotechnology Holdings (CIZ)
Price Change (%)

0.00%


Latest Bid : 1.70p Latest Ask : 1.80p
High Today : 1.75p Low Today : 1.75p
This Years High : 2.60p This Years Low : 1.45p
Volume : 0 MKT Cap : £7.13M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Cizzle Biotechnology Holdings (CIZ) Overview

Cizzle Biotechnology is a spin-out from the University of York and is a biotechnology business focused on the early detection of Lung cancer via the development of an immunoassay test for the CIZ1B biomaker. Cizzle Biotechnology was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test.


You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Cizzle Biotechnology Holdings (CIZ) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 1.70p Latest Ask : 1.80p
High Today : 1.75p Low Today : 1.75p
This Years High : 2.60p This Years Low : 1.45p
Volume : 0 MKT Cap : £7.13M

Cizzle Biotechnology Holdings Overview

Cizzle Biotechnology is a spin-out from the University of York and is a biotechnology business focused on the early detection of Lung cancer via the development of an immunoassay test for the CIZ1B biomaker. Cizzle Biotechnology was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.